← Rita F. Redberg

Papers by Rita F. Redberg

Page 1 · newest first

1. The Regulatory History of the Watchman Left Atrial Appendage Closure DeviceJournal of the American College of Cardiology · 2026
2. Discontinuing Statins in Older Adults without Cardiovascular DiseaseNew England Journal of Medicine · 2026
3. Evaluation of the accuracy, completeness, and compliance of current summary reporting of adverse events to the Food and Drug Administration using the manufacturer and user facility device experience (MAUDE) database: cross sectional studyBMJ · 2026
4. Trends in Adverse Events Reported for Leadless Pacemakers in the United States, Between 2021 and 2024Circulation Population Health and Outcomes · 2026
5. INSPECT-SR tool for assessing trustworthiness of randomised controlled trialsBMJ · 2026
6. The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise EchocardiographyJournal of the American College of Cardiology · 2006
7. Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in WomenJournal of the American College of Cardiology · 2017
8. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference ReportJournal of the American College of Cardiology · 2021
9. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillationJournal of the American College of Cardiology · 2004
10. ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and ProceduresJournal of the American College of Cardiology · 2006
11. ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in AdultsJournal of the American College of Cardiology · 2009
12. Coverage Limitations for Use of Urine Drug Testing in a State Medicaid ProgramJAMA Network Open · 2026
13. ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest PainJournal of the American College of Cardiology · 2007
14. Evaluation of Payer Policies to Reduce Low-Value Medical Device–Based Procedure UseJAMA Health Forum · 2025
15. Insurer Coverage of Invasive Coronary Angiography and Percutaneous Coronary Intervention for Stable Coronary Artery Disease in the United States Compared With Guidelines and Landmark TrialsCirculation Cardiovascular Quality and Outcomes · 2025
16. INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials2025
17. Health Professional Students’ Knowledge About FDA Drug and Medical Device RegulationAcademic Medicine · 2025
18. New Mammography Tools — The Need for Clinically Meaningful Assessment StandardsNew England Journal of Medicine · 2025
19. The Origins of Regulations for Pharmaceutical Products and Medical Devices – What Can be Learned for the Governance of Medical Devices in Europe?European Review · 2025
20. Cost‐effectiveness of early noninvasive cardiac testing for suspected acute coronary syndromeAcademic Emergency Medicine · 2025
21. Barriers and solutions in women’s health research and clinical care: a call to actionThe Lancet Regional Health - Americas · 2025
22. Late adverse event reporting from medical device manufacturers to the US Food and Drug Administration: cross sectional studyBMJ · 2025
23. FAIRS — A Framework for Evaluating the Inclusion of Sex in Clinical AlgorithmsNew England Journal of Medicine · 2025
24. Low Uptake of Lipid Screening—Concerning Nonadherence or Appropriate Skepticism?Archives of Pediatrics and Adolescent Medicine · 2024
25. Physician-Patient Communication about Novel Drugs and High-Risk Medical DevicesMedical Decision Making · 2024
26. Industry Payments to Cardiology Fellows and Early-Career CardiologistsJAMA Internal Medicine · 2024
27. Is more better? A multilevel analysis of percutaneous coronary intervention hospital openings and closures on patient volumesAcademic Emergency Medicine · 2024
28. Funding of Evidence Included Within Public Comments Submitted to Inform Medicare National Coverage DeterminationsHealth Affairs Scholar · 2024
29. Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic strokeOpen Heart · 2024
30. Physicians’ Perspectives On FDA Regulation Of Drugs And Medical Devices: A National SurveyHealth Affairs · 2024
31. Emergency Department Cardiac Risk Stratification With High-Sensitivity vs Conventional Troponin HEART PathwayJAMA Network Open · 2023
32. Quality and transparency of clinical evidence for high-risk cardiovascular medical devices: a long way to goEuropean Heart Journal · 2023
33. Cardiac coronary tomography angiography (CCTA) use across geographical regions in the USA and the UK: a cross-sectional studyBMJ Surgery Interventions & Health Technologies · 2023
34. Studies Of Prescription Digital Therapeutics Often Lack Rigor And InclusivityHealth Affairs · 2023
35. A Critical Examination of Independent Medical Review Decision-making for Cardiovascular Procedures Shows Low Rate of Evidence Citation in ReviewsMedical Care · 2023
36. Unique Device Identifiers—Missing in ActionJAMA Internal Medicine · 2023
37. Trends in FDA Adverse Events Reporting for Inferior Vena Cava Filters and Estimated Insertions in the US, 2016 to 2020JAMA Internal Medicine · 2023
38. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkArchives of Pediatrics and Adolescent Medicine · 2022
39. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkJAMA Network Open · 2022
40. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkJAMA Internal Medicine · 2022
41. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkJAMA Health Forum · 2022
42. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkJAMA · 2022
43. Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA NetworkJAMA Psychiatry · 2022
44. A Policy Approach to Reducing Low‐Value Device‐Based Procedure UseMilbank Quarterly · 2022
45. Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic PainJAMA Neurology · 2022
46. Automated interpretation of stress echocardiography reports using natural language processingEuropean Heart Journal - Digital Health · 2022
47. Statins for Primary Cardiovascular Disease PreventionJAMA Internal Medicine · 2022
48. Medical Device User Fee Reauthorization — Back to Basics or Looking Ahead?New England Journal of Medicine · 2022
49. Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi PanelClinical Pharmacology & Therapeutics · 2022
50. US Food and Drug Administration–Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019JAMA Internal Medicine · 2022